Lipids & metabolic liver disease

Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation

Cardiovasc DiabetolPublished Cross-sectional study

Authors' conclusion

In patients with MD and RA, circulating apoCIII levels were positively associated with glycoproteins and negatively with hsCRP, in a TG-independent manner. Our results suggest that apoCIII is associated with the low-grade inflammatory profile represented by glycoproteins, independent of triglyceride levels. Additionally, we observed a negative association with hsCRP, which, while seemingly paradoxical, has been reported in previous studies.

Study context

Population
Patients with metabolic disorders, patients with rheumatoid arthritis, and controls
Participants
1,242 patients
Exposure
MD vs rheumatoid arthritis (RA) vs Controls
  • MDn = 906
  • RAn = 192
  • Controlsn = 144reference
Outcome
Associations of circulating apoCIII with hsCRP and glycosylated proteins (Glyc-A, Glyc-B, Glyc-F)
Methodological detailsApoCIII and high sensitivity C-reactive protein (hsCRP) by immunoturbidimetric assays; glycosylated proteins by 1 H-NMR spectroscopy; correlation and multivariate linear regression
  • ApoCIII and hsCRP by immunoturbidimetric assays; glycosylated proteins by 1 H-NMR spectroscopy; correlation and multivariate linear regression

Main finding

As reported in the abstract

Associations of apoCIII with inflammation biomarkers
  • ApoCIII significantly and positively associated with Glyc-A, Glyc-B and Glyc-F across all cohorts
  • Most associations remained significant in MD after adjusting for triglyceride (TG)
  • Negative associations between apoCIII and hsCRP in MD and RA, maintained after including TG

Observational data: associations, not effects.

Original publication

Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation. Cardiovasc Diabetol. Published 8 January 2025. doi:10.1186/s12933-024-02553-z

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.